- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x RMJ: 2-[(4-amino-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(piperidin-1-yl)ethyl]acetamide(Non-covalent)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.2: 6 residues within 4Å:- Chain A: E.196, A.197, E.200, R.212, Q.214
- Ligands: GOL.4
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.214
- Water bridges: A:E.200, A:E.200
PEG.3: 11 residues within 4Å:- Chain A: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: DMS.11
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:L.261, A:T.289
- Water bridges: A:A.263, A:A.263, A:Q.417, A:Q.417
PEG.14: 6 residues within 4Å:- Chain B: E.196, A.197, E.200, R.212, Q.214
- Ligands: GOL.16
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.214
- Water bridges: B:E.200, B:E.200
PEG.15: 11 residues within 4Å:- Chain B: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: DMS.23
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:L.261, B:T.289
- Water bridges: B:A.263, B:A.263, B:Q.417, B:Q.417
PEG.26: 6 residues within 4Å:- Chain C: E.196, A.197, E.200, R.212, Q.214
- Ligands: GOL.28
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:Q.214
- Water bridges: C:E.200, C:E.200
PEG.27: 11 residues within 4Å:- Chain C: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: DMS.35
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:L.261, C:T.289
- Water bridges: C:A.263, C:A.263, C:Q.417, C:Q.417
PEG.38: 6 residues within 4Å:- Chain D: E.196, A.197, E.200, R.212, Q.214
- Ligands: GOL.40
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Q.214
- Water bridges: D:E.200
PEG.39: 11 residues within 4Å:- Chain D: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: DMS.47
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:L.261
- Water bridges: D:A.263, D:A.263, D:Q.417, D:Q.417
PEG.50: 6 residues within 4Å:- Chain E: E.196, A.197, E.200, R.212, Q.214
- Ligands: GOL.52
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:Q.214
- Water bridges: E:E.200
PEG.51: 11 residues within 4Å:- Chain E: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: DMS.59
5 PLIP interactions:5 interactions with chain E- Hydrogen bonds: E:L.261
- Water bridges: E:A.263, E:A.263, E:Q.417, E:Q.417
PEG.62: 6 residues within 4Å:- Chain F: E.196, A.197, E.200, R.212, Q.214
- Ligands: GOL.64
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:Q.214
- Water bridges: F:E.200
PEG.63: 11 residues within 4Å:- Chain F: E.260, L.261, R.262, H.269, I.287, I.288, T.289, H.290, D.293, Q.417
- Ligands: DMS.71
5 PLIP interactions:5 interactions with chain F- Hydrogen bonds: F:L.261
- Water bridges: F:A.263, F:A.263, F:Q.417, F:Q.417
- 18 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 2 residues within 4Å:- Chain A: Q.214
- Ligands: PEG.2
Ligand excluded by PLIPGOL.5: 6 residues within 4Å:- Chain A: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.8: 4 residues within 4Å:- Chain A: R.57, T.58, V.60, P.61
Ligand excluded by PLIPGOL.16: 2 residues within 4Å:- Chain B: Q.214
- Ligands: PEG.14
Ligand excluded by PLIPGOL.17: 6 residues within 4Å:- Chain B: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.20: 4 residues within 4Å:- Chain B: R.57, T.58, V.60, P.61
Ligand excluded by PLIPGOL.28: 2 residues within 4Å:- Chain C: Q.214
- Ligands: PEG.26
Ligand excluded by PLIPGOL.29: 6 residues within 4Å:- Chain C: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.32: 4 residues within 4Å:- Chain C: R.57, T.58, V.60, P.61
Ligand excluded by PLIPGOL.40: 2 residues within 4Å:- Chain D: Q.214
- Ligands: PEG.38
Ligand excluded by PLIPGOL.41: 6 residues within 4Å:- Chain D: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.44: 4 residues within 4Å:- Chain D: R.57, T.58, V.60, P.61
Ligand excluded by PLIPGOL.52: 2 residues within 4Å:- Chain E: Q.214
- Ligands: PEG.50
Ligand excluded by PLIPGOL.53: 6 residues within 4Å:- Chain E: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.56: 4 residues within 4Å:- Chain E: R.57, T.58, V.60, P.61
Ligand excluded by PLIPGOL.64: 2 residues within 4Å:- Chain F: Q.214
- Ligands: PEG.62
Ligand excluded by PLIPGOL.65: 6 residues within 4Å:- Chain F: H.125, R.126, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.68: 4 residues within 4Å:- Chain F: R.57, T.58, V.60, P.61
Ligand excluded by PLIP- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 9 residues within 4Å:- Chain A: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.7: 6 residues within 4Å:- Chain A: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.10: 7 residues within 4Å:- Chain A: A.367, E.368, I.369, E.370, R.396, T.397, K.398
Ligand excluded by PLIPSO4.18: 9 residues within 4Å:- Chain B: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.19: 6 residues within 4Å:- Chain B: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.22: 7 residues within 4Å:- Chain B: A.367, E.368, I.369, E.370, R.396, T.397, K.398
Ligand excluded by PLIPSO4.30: 9 residues within 4Å:- Chain C: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.31: 6 residues within 4Å:- Chain C: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.34: 7 residues within 4Å:- Chain C: A.367, E.368, I.369, E.370, R.396, T.397, K.398
Ligand excluded by PLIPSO4.42: 9 residues within 4Å:- Chain D: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.43: 6 residues within 4Å:- Chain D: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.46: 7 residues within 4Å:- Chain D: A.367, E.368, I.369, E.370, R.396, T.397, K.398
Ligand excluded by PLIPSO4.54: 9 residues within 4Å:- Chain E: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.55: 6 residues within 4Å:- Chain E: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.58: 7 residues within 4Å:- Chain E: A.367, E.368, I.369, E.370, R.396, T.397, K.398
Ligand excluded by PLIPSO4.66: 9 residues within 4Å:- Chain F: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, S.412, D.413
Ligand excluded by PLIPSO4.67: 6 residues within 4Å:- Chain F: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPSO4.70: 7 residues within 4Å:- Chain F: A.367, E.368, I.369, E.370, R.396, T.397, K.398
Ligand excluded by PLIP- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.9: 2 residues within 4Å:- Chain A: E.159, W.309
3 PLIP interactions:3 interactions with chain A- Salt bridges: A:E.159
- pi-Cation interactions: A:W.309, A:W.309
DMS.11: 7 residues within 4Å:- Chain A: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.3
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.418, A:T.418
DMS.21: 2 residues within 4Å:- Chain B: E.159, W.309
3 PLIP interactions:3 interactions with chain B- Salt bridges: B:E.159
- pi-Cation interactions: B:W.309, B:W.309
DMS.23: 7 residues within 4Å:- Chain B: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.15
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.418, B:T.418
DMS.33: 2 residues within 4Å:- Chain C: E.159, W.309
3 PLIP interactions:3 interactions with chain C- Salt bridges: C:E.159
- pi-Cation interactions: C:W.309, C:W.309
DMS.35: 7 residues within 4Å:- Chain C: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.27
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:T.418, C:T.418
DMS.45: 2 residues within 4Å:- Chain D: E.159, W.309
3 PLIP interactions:3 interactions with chain D- Salt bridges: D:E.159
- pi-Cation interactions: D:W.309, D:W.309
DMS.47: 7 residues within 4Å:- Chain D: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.39
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:T.418
DMS.57: 2 residues within 4Å:- Chain E: E.159, W.309
3 PLIP interactions:3 interactions with chain E- Salt bridges: E:E.159
- pi-Cation interactions: E:W.309, E:W.309
DMS.59: 7 residues within 4Å:- Chain E: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.51
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:T.418
DMS.69: 2 residues within 4Å:- Chain F: E.159, W.309
3 PLIP interactions:3 interactions with chain F- Salt bridges: F:E.159
- pi-Cation interactions: F:W.309, F:W.309
DMS.71: 7 residues within 4Å:- Chain F: R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.63
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:T.418
- 6 x NA: SODIUM ION(Non-functional Binders)
NA.12: 2 residues within 4Å:- Chain A: S.338, E.368
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:E.368
NA.24: 2 residues within 4Å:- Chain B: S.338, E.368
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.368
NA.36: 2 residues within 4Å:- Chain C: S.338, E.368
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.338
NA.48: 2 residues within 4Å:- Chain D: S.338, E.368
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:S.338
NA.60: 2 residues within 4Å:- Chain E: S.338, E.368
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:E.368
NA.72: 2 residues within 4Å:- Chain F: S.338, E.368
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:S.338
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis fromMycobacterium tuberculosis. Acs Chem.Biol. (2020)
- Release Date
- 2020-06-03
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x RMJ: 2-[(4-amino-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(piperidin-1-yl)ethyl]acetamide(Non-covalent)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 18 x GOL: GLYCEROL(Non-functional Binders)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 6 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis fromMycobacterium tuberculosis. Acs Chem.Biol. (2020)
- Release Date
- 2020-06-03
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A